China’s Sinovac secures $515m to boost COVID-19 vaccine production

China’s Sinovac secures $515m to boost COVID-19 vaccine production

Photo by Louis Reed on Unsplash

China’s Sinovac Biotech has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter